Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018

Meropenem/Vaborbactam (MEM-VAB) is a novel carbapenem- β-lactamase inhibitor active against KPC-producing Enterobacteria. Herein, we evaluate the incidence of meropenem/vaborbactam-resistance among KPC-producing K. pneumoniae (KPC-Kp) bloodstream infection in a large Italian hospital. Meropenem/vabo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaibani, Paolo, Lombardo, Donatella, Bussini, Linda, Bovo, Federica, Munari, Beatrice, Giannella, Maddalena, Bartoletti, Michele, Viale, Pierluigi, Lazzarotto, Tiziana, Ambretti, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148119/
https://www.ncbi.nlm.nih.gov/pubmed/34066420
http://dx.doi.org/10.3390/antibiotics10050536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148119/
https://www.ncbi.nlm.nih.gov/pubmed/34066420
http://dx.doi.org/10.3390/antibiotics10050536

Ejemplares similares